Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation and patient access to treatments.
Related Posts
Trump picks vaccine skeptic RFK Jr. for Health and Human Services secretary
Donald Trump had said that if elected president he would have Robert F. Kennedy Jr. “go wild on health.” HHS oversees Medicare, Medicaid, CDC and […]
Goldman Sachs upgrades Norwegian Cruise Line, says stock is primed for a strong 2025
A strong year and outlook for the cruise industry has Goldman Sachs forecasting more gains for Norwegian Cruise Line Holdings in 2025.
Retailers brace for DEI blowback in lead-up to election, holiday shopping season
Some companies are concerned about attending public DEI events while others are strategizing on how to avoid criticism over their policies and programs.